Evidence map›Paper›PMID 38192370›Full record

ReviewFrontiers in pediatrics2023

Acute gastroenteritis-changes to the recommended original oral rehydrating salts: a review.

Carlos Lifschitz, Oleksii Kozhevnikov, Christine Oesterling, Amira Anbar, Steven Walker

Open access · goldAbstract readReview
In one paragraph

Review in Frontiers in pediatrics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.4field-weighted citation impact, top 38% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 5 institutions in 3 countries.

Carlos LifschitzHospital Italiano de Buenos Aires, Buenos Aires, Argentina.
Oleksii KozhevnikovMedibiotiX GmbH, Baden-Baden, Germany.
Christine OesterlingEastmead Surgery, Greenford, and Imperial College London, London, United Kingdom.
Amira AnbarSt. Gilesmedical, London, United Kingdom.
Steven WalkerSt. Gilesmedical (London & Berlin) & University of Applied Sciences, Bremen, Germany.
CellGenix (Germany) · DEHochschule Bremen · DEHospital Italiano de Buenos Aires · ARImperial College London · GBIQVIA (United Kingdom) · GB

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The World Health Organization recommended a formulation of oral rehydration salts as the intervention of choice for the treatment of acute gastroenteritis. While of value for the replacement of fluids and electrolytes, the formulation does not reduce stool volume, frequency, or symptom duration. This may prevent wide acceptance. To increase tolerability, shorten the duration of diarrhea and improve parental quality of life, several modifications to the original formula have been proposed. These include; low osmolarity, rice-based, glucose polymers as an alternative to glucose, the addition of probiotics, prebiotics and/or zinc, and various other ingredients. Here we summarize evidence regarding such changes and additions.

Indexed as

acute gastroenteritis (AGE)low osmolar oral rehydration solutionoral rehydrating solutionprobiotics and prebioticsreviewrotavirus diarrheazinc

Identifiers

PMID38192370
PMCPMC10773804
OpenAlexW4389912413

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.